Citation Impact
Citing Papers
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
2014
Analysis of 388 cases of primary sclerosing cholangitis in JapanPresence of a subgroup without pancreatic involvement in older patients
2004
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
2018
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
2020
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
2019
Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State
2013
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Works of Hideki Kobara being referenced
Responses of renal hemodynamics and tubular functions to acute sodium–glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats
2017
Concomitant colitis associated with primary sclerosing cholangitis
2003
A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor–dependent pathway after renal injury in mice
2018
Antitumor effect of metformin in esophageal cancer: In vitro study
2012
Metabolic Syndrome, Obesity, and Gastrointestinal Cancer
2012